7 Medical Claims That Now Require Manual Review

In the fast-paced world of digital healthcare, patients have grow to be accustomed to “real-time” adjudication, where a claim is processed and a copay is set before they even leave the doctor’s office. However, in 2026, a big percentage of medical claims will experience an acceleration. To combat fraud and address the rising costs of complex therapies, insurance carriers have recalibrated their algorithms to flag certain categories of take care of “manual clinical review.”

This shift implies that as an alternative of being immediately approved by a pc, your application is pulled from the digital stack and placed in a queue to be read by a human nurse or medical coder. For the patient, this transition from “automatic assessment” to “manual review” represents a mysterious delay. Their online portal shows the claim as “Pending” or “In Process” for weeks, often resulting in concerns about whether the bill will ultimately be covered. Knowing which services will trigger this pause will make it easier to prepare for the delay and gather the mandatory documentation before the inevitable request for documentation arrives. Here are the seven medical claims that may almost actually trigger manual review in 2026.

1. Genetic and molecular testing panels

The most studied category in 2026 is genetic testing. After a large wave of fraud related to telemarketing “cancer screening” schemes, insurers have sharply curbed automated payments for these expensive lab tests. Accordingly Federal fraud warnings regarding genetic testingPayers now manually review claims to make sure the particular gene panel ordered is an ideal match to the patient’s family history and diagnosis codes.

If your doctor orders a comprehensive “pan-cancer” screening as an alternative of targeted testing for a selected mutation, the claim will likely be reviewed while the insurer requests the doctor’s clinical findings to exhibit medical necessity. This delay is meant to forestall “stamp recipes”. But for eligible patients, which means they’ll need to wait months to seek out out if their $4,000 test is roofed.

2. Level 5 emergency room visits

If you go to the emergency room for a major problem but are discharged the identical day, your claim is a chief goal for a “clinical validation review.” Insurers like Aetna and Cigna have strict downcoding policies in place This level 5 (high severity) flag requires manual review if the patient has not been hospitalized.

Instead of mechanically paying the Level 5 rate, the insurer pauses the claim to see if a human reviewer can downgrade it to a less expensive Level 3 or 4 rate based on the discharge summary. This process often leaves the patient facing an uncertain “patient responsibility amount” for months while the hospital appeals the choice.

3. Modifiers 25 and 59 “Unbundling”

One of essentially the most technical triggers for a manual review is the usage of Modifier 25 (separate E/M visit) and Modifier 59 (different procedure). These codes allow doctors to bill for 2 services in a single visit, equivalent to an exam and mole removal. Due to widespread overuse 2026 coding updates have made these modifiers a chief goal for “verification before payment.”

Claims containing these modifiers are sometimes used to verify that the physician actually provided two different services, slightly than simply unbundling a single interaction to receives a commission twice. If your Explanation of Benefits (EOB) is delayed, it is actually because the insurer is reading the notes to see if this “separate review” actually took place.

4. Inpatient rehabilitation admissions

Due to manual “pre-payment” checks, approval for a stay in an acute rehabilitation facility after a stroke or surgery becomes rather more difficult. Insurers strictly implement the factors set out within the policy CMS FY 2026 Final Rule for Inpatient Rehabilitation Facilities.

Payers now not depend on the hospital’s trust; You manually review the each day therapy protocols for the primary few days of your stay. If the notes indicate that the patient was too drained to finish the mandatory three hours of therapy, the insurer can retroactively deny your entire admission as “customary care,” forcing the ability to bill the patient or file an appeal.

5. Biological Drug Waste (The JZ Modifier)

The high cost of biologic drugs – often 1000’s of dollars per vial – has led to strict latest rules regarding “waste.” If a patient requires 400 mg of a medication but it surely is supplied in disposable 500 mg vials, the remaining 100 mg can be discarded. Under the 2026 Medicare Physician Fee ScheduleProviders must use certain codes (equivalent to the JZ modifier) ​​to verify that they’ve discarded the surplus.

Insurance auditors manually review these claims to be sure that the quantity billed as “wasted” matches the drug package size and the patient’s weight-based dose. This ensures that clinics don’t “harvest” any leftovers when billing for full bottles.

6. Physiological Remote Monitoring (RPM)

The popularity of distant patient monitoring has exploded, but 2026 brings a crackdown on “autopilot” billing. Insurers review claims for codes like CPT 99454 (device care) to make sure patients are literally using the devices.

UnitedHealthcare 2026 Policy Updates Limit coverage of RPM particularly for easy hypertension or type 2 diabetes and require manual review to exhibit that monitoring prevents hospitalization. If you may have an attached blood pressure cuff, your monthly claim could also be placed on hold while the insurer reviews data logs to make sure you are uploading readings continuously enough to justify the price.

7. Procedure codes not listed

As AI and robotic surgery rapidly advance, physicians often use “unlisted codes” (e.g., CPT 64999) for brand new technologies that don’t yet have a everlasting billing code. By definition, an unlisted code can’t be assessed mechanically as there isn’t any set price.

Each individual procedure requires a human adjuster to read the document We create an operational report and determine a good price. This manual pricing process can delay billing by 60 to 90 days and leave the patient in limbo while insurers and providers haggle over the worth of the brand new process.

Don’t panic, but don’t ignore it

If your claim gets stuck in “Manual Review,” it doesn’t necessarily mean it can be rejected; it means it’s being watched. The most significant step you possibly can take is to observe your insurance portal weekly. If the status stays “pending” for greater than 30 days, call your provider – not the insurance company. Ask the billing department, “Have you received and been sent a request for medical records related to this claim?” Often the request is rejected just because the doctor’s office missed the deadline to fax the requested notes. This is a writing mistake that you would be able to prevent by staying vigilant.

Has your genetic test or emergency room visit been stuck in “pending” status for months? Leave a comment below – your story will help other readers learn the way long these manual checks really take.

You may also like…